Cite
Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 1 6, and 1 8) Vaccine in HIV-lnfected Children 7 to 1 2 Years Old.
MLA
Levin, Myron J., et al. “Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 1 6, and 1 8) Vaccine in HIV-Lnfected Children 7 to 1 2 Years Old.” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 2, Oct. 2010, pp. 197–204. EBSCOhost, https://doi.org/10.1097/QAI.0b013e3181de8d26.
APA
Levin, M. J., Moscicki, A.-B., Lin-Ye Song, Fenton, T., William A. Meyer, I., Read, J. S., Handelsinan, E. L., Nowak, B., Sattler, C. A., Saah, A., Radley, D. R., Esser, M. T., & Weinberg, A. (2010). Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 1 6, and 1 8) Vaccine in HIV-lnfected Children 7 to 1 2 Years Old. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 55(2), 197–204. https://doi.org/10.1097/QAI.0b013e3181de8d26
Chicago
Levin, Myron J., Anna-Barbara Moscicki, Lin-Ye Song, Terrence Fenton, Iii William A. Meyer, Jenn!fer S. Read, Edward L. Handelsinan, et al. 2010. “Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 1 6, and 1 8) Vaccine in HIV-Lnfected Children 7 to 1 2 Years Old.” JAIDS: Journal of Acquired Immune Deficiency Syndromes 55 (2): 197–204. doi:10.1097/QAI.0b013e3181de8d26.